Head and Neck Neoplasm Clinical Trial
Official title:
Therapeutic HPV Vaccine (BNT113) Trial in HPV16 Driven Carcinoma
HARE-40 is a phase I/II vaccine dose escalation study with two different arms: Arm 1A will perform intrapatient dose escalation in patients with previously treated HPV16+ Head & Neck Cancer using two dose cohorts to establish a safe, tolerable and recommended dose of HPV vaccine. Arm 1B will perform intrapatient dose escalation in patients with advanced HPV16+ cancer (head and neck, anogenital, penile, cervical and other) using a single cohort to establish a safe, tolerable and recommended dose of HPV vaccine.
HARE-40 is a phase I/II vaccine dose escalation trial with two arms (Arm 1A and Arm 1B) in which we will test BNT113 as monotherapy. We will undertake a multi-centre phase I, open label trial in patients with previous HPV16+ HNSCC without current clinical evidence of disease (Arm 1A) and in patients with HPV16+ advanced disease (Arm 1B). The HPV16 antigen-specific immune response will be evaluated before and after treatment in circulating blood and, where samples have been collected, in tumour and skin biopsies. Arms 1A and 1B will escalate BNT113 in each patient (intrapatient dose escalation) up to the specified target dose of the cohort to establish a safe, tolerable and recommended dose of BNT113 in patents who are disease free (Arm 1A) and those with advanced disease (Arm 1B). Subset of patients in Arm 1B will also be assessed for response to the vaccine in terms of a significant increase of immune cells following BNT113 administration and according to irRECIST1.1 (all 29 patients including the expansion cohort) and other endpoints. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02960308 -
Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors
|
||
Terminated |
NCT02602067 -
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
|
Phase 1 | |
Completed |
NCT04277273 -
Characteristics of a Maxillofacial Prosthesis Consultation Within Assistance Publique - Hopitaux de Paris
|
N/A | |
Completed |
NCT03896906 -
Preoxygenation With a High-flow Nasal Cannula or a Simple Mask Before General Anesthesia in Head and Neck Surgery
|
N/A | |
Completed |
NCT01621295 -
Assessing the Patient Experience in Cancer Care
|
N/A | |
Active, not recruiting |
NCT03854838 -
IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.
|
Phase 2 | |
Completed |
NCT04151030 -
Endoscopic Direct-PEG Placement in Patients Unable to Undergo Pull-PEG Procedure
|
N/A | |
Completed |
NCT03012581 -
Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
|
Phase 2 | |
Active, not recruiting |
NCT04005521 -
Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer
|
N/A | |
Recruiting |
NCT05011500 -
Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC)
|
N/A | |
Completed |
NCT05590650 -
A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients
|
Phase 1 | |
Terminated |
NCT03402737 -
SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N
|
N/A | |
Completed |
NCT04086849 -
Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
|
||
Completed |
NCT00001442 -
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer
|
Phase 1 | |
Recruiting |
NCT04477759 -
Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer
|
Phase 1 | |
Terminated |
NCT00423150 -
Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED)
|
Phase 2 | |
Recruiting |
NCT03757091 -
Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery
|
N/A | |
Recruiting |
NCT04099290 -
Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
|
||
Withdrawn |
NCT04679233 -
Feasibility and Safety of Aerobic Exercise for Head and Neck Cancer Patients
|
N/A | |
Not yet recruiting |
NCT04267627 -
Telemedicine Nurse-Led Intervention for Rural Cancer Survivors
|
N/A |